Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![David T. Rubin, MD, FACG and Jennifer Labas, FNP-BC: Case Discussion: Managing Severe UC in the Hospital Setting: Novel Approaches]()
David T. Rubin, MD, FACG and Jennifer Labas, FNP-BC: Case Discussion: Managing Severe UC in the Hospital Setting: Novel Approaches
29/07/2018 Duración: 24minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![David T. Rubin, MD, FACG: Bench-to-bedside Topline Review for 2018: New Targets and the IBD Pipeline]()
David T. Rubin, MD, FACG: Bench-to-bedside Topline Review for 2018: New Targets and the IBD Pipeline
29/07/2018 Duración: 19minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![Russell D. Cohen, MD, FACG: The role of JAK inhibitors in your clinical practice]()
Russell D. Cohen, MD, FACG: The role of JAK inhibitors in your clinical practice
29/07/2018 Duración: 15minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![Stephen B. Hanauer, MD, FACG: Optimizing therapy for mild to moderate IBD: Pearls for our foundational agents, 5-ASA, corticosteroids and immunomodulators]()
Stephen B. Hanauer, MD, FACG: Optimizing therapy for mild to moderate IBD: Pearls for our foundational agents, 5-ASA, corticosteroids and immunomodulators
29/07/2018 Duración: 17minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![David P. Hudesman, MD: Management and prevention of infection in IBD]()
David P. Hudesman, MD: Management and prevention of infection in IBD
29/07/2018 Duración: 17minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![David T. Rubin, MD, FACG: When and how to de-escalate therapy in IBD]()
David T. Rubin, MD, FACG: When and how to de-escalate therapy in IBD
29/07/2018 Duración: 26minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![Stephen B. Hanauer, MD, FACG: How should we position newer biologics in our current therapeutic algorithms?]()
Stephen B. Hanauer, MD, FACG: How should we position newer biologics in our current therapeutic algorithms?
29/07/2018 Duración: 22minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![Jean-Frederic Colombel, MD: Keynote Lecture: Treating to target in 2018: When and how to do it]()
Jean-Frederic Colombel, MD: Keynote Lecture: Treating to target in 2018: When and how to do it
29/07/2018 Duración: 23minWebcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
-
![Aimery De Gramont: Celebration Lecture: The history of GI cancer: What has been achieved over the last 20 years?]()
Aimery De Gramont: Celebration Lecture: The history of GI cancer: What has been achieved over the last 20 years?
20/07/2018 Duración: 14minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Theirry André: Can we refine the selection for adjuvant treatment in stage III colon cancer?]()
Theirry André: Can we refine the selection for adjuvant treatment in stage III colon cancer?
20/07/2018 Duración: 17minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Axel Grothey: Can we refine the selection for adjuvant treatment in stage II colon cancer?]()
Axel Grothey: Can we refine the selection for adjuvant treatment in stage II colon cancer?
20/07/2018 Duración: 16minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Ramon Salazar: Discussion of colorectal cancer abstracts presented at ESMO GI]()
Ramon Salazar: Discussion of colorectal cancer abstracts presented at ESMO GI
20/07/2018 Duración: 15minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Heinz-Josef Lenz: How to improve on the outcome in RAS mutant tumors]()
Heinz-Josef Lenz: How to improve on the outcome in RAS mutant tumors
20/07/2018 Duración: 26minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Volker Heinemann: The left versus right colon cancer story: What is the truth?]()
Volker Heinemann: The left versus right colon cancer story: What is the truth?
20/07/2018 Duración: 14minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Dan Aderka: Explaining the unexplainable: CALGB vs FIRE-3 discrepant data]()
Dan Aderka: Explaining the unexplainable: CALGB vs FIRE-3 discrepant data
20/07/2018 Duración: 17minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![David Cunningham: Selecting the optimal first-line treatment in advanced colorectal cancer]()
David Cunningham: Selecting the optimal first-line treatment in advanced colorectal cancer
20/07/2018 Duración: 12minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Jean-Yves Douillard: How can we deal with the explosion of new treatments? - ESMO]()
Jean-Yves Douillard: How can we deal with the explosion of new treatments? - ESMO
20/07/2018 Duración: 19minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Jorge Camarero: How can we deal with the explosion of new treatments? - EMA]()
Jorge Camarero: How can we deal with the explosion of new treatments? - EMA
20/07/2018 Duración: 16minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Steven Lemery: How can we deal with the explosion of new treatments? - FDA]()
Steven Lemery: How can we deal with the explosion of new treatments? - FDA
20/07/2018 Duración: 18minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
-
![Ali Shamseddine: What do the new evolutions in GI cancer mean for my practice? - Middle East]()
Ali Shamseddine: What do the new evolutions in GI cancer mean for my practice? - Middle East
20/07/2018 Duración: 14minWebcast: ESMO 20th World Congress on Gastrointestinal Cancer
